Vitamin D and bone health: Is there a need to review supplementation in osteoporosis risk population?;Vitamina D y salud ósea: ¿Es necesario revisar la administración de sus suplementos en poblaciones de riesgo de osteoporosis?

Medicina Clinica

Volumn 125, Issue 20, 2005, Pages

  Del Campo, M Teresa ^a   Aguado, Pilar ^a   Martínez, M Eugenia ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Calcidiol; Calcium; Cholecalciferol; Fracture prevention; Osteoporosis; Vitamin D

Indexed keywords

25 HYDROXYERGOCALCIFEROL; COLECALCIFEROL; VITAMIN D;

BONE DENSITY; BONE METABOLISM; BONE MINERAL; DRUG EFFECT; FRACTURE; HIGH RISK POPULATION; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; SPAIN; VITAMIN D DEFICIENCY;

EID: 29944445391     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(05)72191-6     Document Type: Review

References (54)

1. Heaney RP. Vitamin D: how much do we need, and how much is too much? Osteoporos Int. 2000;11:553-5.
2. Boonen S, Rizzoli R, Meunier PJ, Stone M, Nuki G, Syversen U, et al. The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int. 2004; 15:511-9.
3. NIH Consensus Development Panel on Osteoporosis. Osteoporosis prevention, diagnosis and therapy. JAMA. 2001;285:785-95.
4. Kanis JA. Assessment of fracture risk and its applications to screening for postmenopausal osteoporosis: Synopsis of a WHO report. Osteoporosis Int. 1994;4:368-1.
5. Fonseca V, Afnew JE, Nag D. Bone density and cortical thickness in nutricional vitamin D deficiency: effect on secondary hyperparathyroidism. Am Clin Biochem. 1988;25:271-4.
6. Luckert B, Higgins J, Stoskopf M. Menopausal bone loss is partially regulated by dietary intake of vitamin D. Calcif Tissue Int. 1992;51:173-9.
7. Villarreal DT, Civitelli R, Chines A, Avioli LV. Subclinical vitamin D deficiency in postmenopausal with low vertebral bone mass. J Clin Endocrinol Metab. 1991;72:628-34.
8. Mezquita-Raya P, Muñoz-Torres M, Luna J, Luna V, López-Rodríguez F, Torres-Vela E, et al. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J Bone Miner Res. 2001;16:1408-15.
9. Khaw KT, Sneyd MJ, Compston J. Bone density, parathyroid hormone and 25-hidroxyvitamin D concentrations in middle aged women. BMJ. 1992;305:273-7.
10. Del Puente A, Espósito A, Savastano S, Carpinelli A, Postiglione L, Oriente P. Dietary calcium intake and serum vitamin D are major determinants of bone mass variations in women. A longitudinal study. Aging Clin Exp Res. 2002;14:382-8.
11. Martínez ME, Del Campo MT, Sánchez-Cabezudo MJ, García JA, Sánchez-Calvín MT, Torrijos A, et al. Relation between calcidiol serum levels and bone mineral density in postmenopausal women with low bone density. Calcif Tissue Int. 1994;55:253-6.
12. Sherman SS, Hollis BW, Tobin JD. Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season. J Clin Endocrinol Metab. 1990;71:405-13.
13. Tsai KS, Wahner HW, Offord KP, Melton LJ, Kumar R, Riggs BL. Effect of aging on vitamin D stores and bone density in women. Calcif Tissue. 1987;40:241-3.
14. Aguado P, Del Campo MT, Garcés MV, González-Casaús ML, Bernad M, Gijón-Baños J, et al. Low vitamin D levels in outpatient postmenopausal women from a Rheumatology Clinic in Madrid, Spain: Their relationship with bone mineral density. Osteoporos Int. 2000;11:739-44.
15. Baker MR, McDonell H, Peacock M, Nordin BEC. Plasma 25-hydroxyvitamin D concentrations in patients with fractures of the femoral neck. BMJ. 1979;1:589-90.
16. Lips P, Van Ginkel FC, Jongen MJM, Rubertus A, Van der Vijgh WJF, Netelenbos JC. Determinants of vitamin D status in patients with hip fracture and elderly control subjects. Am J Clin Nutr. 1987;46:1005-10.
17. Cooper C, McLaren M, Wood PJ, Coulton L, Kanis JA. Indices of calcium metabolism in women with hip fractures. Bone Miner. 1989;5:193-200.
18. Falch JA, Mowé M, Bomer T, Haug E. Serum levels of intact parathyroid hormone in elderly patients with hip fracture living at home. Acta Endocrinol. 1992;126:10-2.
19. Benhamou CL, Tourliere D, Gauvain JB, Picaper P, Audran M, Jallet P. Calciotropic hormones in elderly people with and without hip fracture. Osteoporosis Int. 1995;5:103-7.
20. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowaki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA. 1999;281:1505-11.
21. Weatherall M. A meta-analysis of 25 hydroxyvitamin D in older people with fracture of the proximal femur. N Z Med J. 2000;113:137-40.
22. Martínez ME, Del Campo MT, Sánchez-Cabezudo MJ, García JA, Medina S, García-Cimbrelo E, et al. Concentraciones de vitamina D en pacientes con fractura de cadera en Madrid. Med Clin (Barc). 1996;106:41-4.
23. Dandona P, Menon RK, Shenoy R, Houlder S, Thomas M, Mallison WJW. Low 1,25-Dyhydroxyvitamin D, secondary hyperparathyroidism, and normal osteocalcin in elderly subjects. J Clin Endocrinol Metab. 1986;63:459-62.
24. Quesada JM, Coopmans W, Ruiz B. Influence of vitamin D on parathyroidism function in the elderly. J Clin Endocrinol Metab. 1993;75:494-501.
25. Slovik DM, Adams JS, Neer RM, Holick MF, Potts JT. Deficient production of 1,25 dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med. 1981;305:372-4.
26. Tsak KS, Wahner HW, Offord KP, Melton LJ, Kumar R, Riggs BL. Effect of aging on vitamin D stores and bone density in women. Calcif Tissue Int. 1987;40:241-3.
27. Boonen S, Vanderschueren D, Cheng XG, Verbeke G, Dequeker J, Geusens P, et al. Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption. J Bone Miner Res. 1997;12:2119-26.
28. 3-induced response of various osteoblastic markers in human osteoblastic cells. Bone. 1999;24:203-9.
29. McDonald D, Lau E, Chan ELP, Mak T, Woo J, Leung PC. Serum intact parathyroid hormone levels in elderly Chinese females with hip fracture. Calcif Tissue Int. 1992;51:412-4.
30. McKenna MJ, Freaney R. Secondary hyperparathyroidism in the elderly: means to defining hypovitamonosis D. Osteoporos Int. 1998;8 Suppl 2:S3-6.
31. Martínez ME, Del Campo MT. Vitamina D. En: Hernández M, Sastre A, editores. Tratado de nutrición. Madrid: Díaz de Santos; 1999. p. 203-15.
32. Holick MF. Vitamin D: Photobiology, metabolism, mechanism of action, and clinical applications. En: Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. Favus MJ, editor. New York: Raven Press; 1996. p. 74-81.
33. Van der Wielen RPJ, Löwik MRH, Van den Berg H, De Groot LCPGM, Haller J, Moreiras O. Serum vitamin D concentrations among elderly people in Europe. Lancet. 1995;346:207-10.
34. Larrosa M, Gratacos J, Vaqueiro M, Prat M, Campos F, Roque M. Prevalence of hipovitaminosis D in elderly institutionalized residents: influence of a substitutive treatment. Med Clin (Barc). 2001;117:611-4.
35. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med. 1992;93:67-9.
36. Thomas MK, Kihhoyd-Jones DM, Thadhani RI, Show AC, Desraska DJ, Kitch E. Hypovitaminosis D in medical inpatients. New Eng J Med. 1998; 338:777-83.
37. Bettica P, Bevilacqua M, Vago T, Norbiato G. High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in Northern Italy for initial screening. Osteoporosis Int. 1999;9:226-9.
38. Holick MF. Vitamin D: New horizons for the 21st century. Am J Clin Nutr. 1994;60:619-30.
39. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842-56.
40. Kauppinen-Makelin R, Tahtela R, Loyttyniemi E, Karkkainen J, Valimaki MJ. A high prevalence of hypovitaminosis D in Finnish medical in- and outpatients. J Intern Med. 2001;249:559-63.
41. Chen TC, Heath H, Holick MF. An update on the vitamin D content of fortified milk from the United States and Canada. N Engl J Med. 1993; 329:1507.
42. European Commission. Report on osteoporosis in the European Community: action on prevention. Luxembourg: Office for Official Publications of the European Communities; 1998. p. 112.
43. Institute of Medicine, Standing Comittee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intake: calcium, phosphorus, vitamin D, and fluoride. Washington, DC: National Academy Press; 2000.
44. 3 and calcium to prevent hip fracture in elderly women. N Engl J Med. 1992;327:1637-42.
45. 3 supplementation is cost-effective in hip fractures prevention. Maturitas. 2003;44:299-305.
46. Lips P, Graafmanss WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Int Med. 1996;124:400-6.
47. Dawson-Hughes B, Harris SS, Krall EA, Dallai GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670-6.
48. Gillespie WJ, Avenell A, Henry DA, O'Connell DL, Robertson J. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis (Cochrane Review). Oxford: Update Software. The Cochrane Library, Issue 4; 2000.
49. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326:469-78.
50. Papadimitropoulos E, Wells G, Shea B, Gillespie W, Weaver B, Zytaruk N, et al. Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocrine Reviews. 2002; 23:560-9.
51. 3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73:288-94.
52. Burns J, Paterson CR. Single dose vitamin D treatment for osteomalacia in the elderly. Br Med J (Clin Res Ed). 1985;290:281-2.
53. Weisman Y, Schen RJ, Eisenberg Z. Single oral high-dose vitamin D, prophylaxis in the elderly. J Am Geriatr Soc. 1986;34:515-8.
54. Aguado P, Garcés MV, Gonzalez Casaús ML, Del Campo MT, Martínez ME. Alta prevalencia de deficiencia de vitamina D en mujeres postmenopáusicas en Madrid. Evaluación de dos pautas de tratamiento. Med Clin (Barc). 2000;114:326-30.